• We are pleased to share a poster presentation made at the 2019 ASCO Annual Meeting. This presentation contains work by Northwestern University clinicians and scientists demonstrating biodistribution and tolerability data from a Phase 0 first-in-human study of NU-0129, a gold-based SNA targeting the Bcl2L12 gene. The study was conducted in… Read More..

  • CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Exicure, Inc. (XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CFO, David Snyder, will give a company presentation on Tuesday, June 4th, 2019 at 3:40-4:00 pm MDT at the LD Micro 9th Invitational Conference.… Read More..

  • VANCOUVER, British Columbia, June 03, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in multiple upcoming investment and industry conferences in June. Lift & Co. Cannabis Expo Allan Rewak, Vice President, Communications & Stakeholder Relations, will participate on a panel and be available… Read More..